Replies to post #356138 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

It is still a supplier with shares and was reported on in the annual financial reports. I am not wrong, I already conceded that they have no regulatory duty to report their sales. However, NWBO has reported on their manufacturing and has included the ownership details in their financial reporting.

[biosectinvestor]

So you’re answer here, insists I am wrong by repeating what I said in different words on the one hand: yes, I said they are below the required amount that would make COGNATE disclose.

Then you say, you are wrong, IT is not updated at all, when I said THAT report is no longer a requirement. It’s typical, rhetorical nonsense from a “skeptic”. It is a part of the NWBO annual report. While mentioning it is not required, necessarily, I don’t know why they would have included it there at all if they did not think it was a necessary and relevant detail, the clarity will come when they next publish their annual report and if they are still discussed as a supplier, with a substantial stake in the company. I don’t think they will take it out if it is still true. And I do not think they will repeat it if it is not true.

That is the nature of such reports, much that is in them gets repeated, annually, unless it is no longer true. Taking out details like that can create incorrect impressions.

However, the key part that you seem to assume is they won’t be discussing who will manufacture for them in North America. I think it will be in there or, if no longer true, that section will substantially change. I do not expect that it will change in that manner however, given the long relationship and the buyout.